Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
University of Nebraska President Dr. Jeffrey Gold joined us to share practical health and safety guidance for managing respiratory and skin health during the winter season.
Roger McEowen with the Washburn University School of Law joined us to provide legal analysis on key cases shaping the agricultural landscape heading into the year ahead.
NASDA declared 2026 the International Year of the Woman Farmer. President Amanda Beal joins us to share NASDA’s new hub, which highlights the impact of women in agriculture worldwide.
The American Farm Bureau Federation’s 2026 agenda centers on labor stability, biosecurity, and economic resilience for family farms. Expanded DMC coverage improves risk protection for dairy operations facing tighter margins.
Agronomy experts explain why standing crop residue protects soil and reduces costs for crop growers, while shredding often yields little benefit at higher costs.
Texas Agriculture Commissioner Sid Miller today unveiled a bold plan to protect the nation’s prime farm and ranchland from the rapid spread of data centers.
